House Bill 3871e1

CODING: Words stricken are deletions; words underlined are additions.






                                      HB 3871, First Engrossed/ntc



  1                      A bill to be entitled

  2         An act relating to product liability; amending

  3         s. 95.031, F.S.; providing a time period for

  4         bringing an action for product liability or

  5         fraud; providing an exception; creating s.

  6         768.1256, F.S.; providing a government rules

  7         defense with respect to certain product

  8         liability actions; providing for a rebuttable

  9         presumption; providing requirements with

10         respect to products which are drugs; providing

11         an effective date.

12

13  Be It Enacted by the Legislature of the State of Florida:

14

15         Section 1.  Subsection (2) of section 95.031, Florida

16  Statutes, is amended to read:

17         95.031  Computation of time.--Except as provided in

18  subsection (2) and in s. 95.051 and elsewhere in these

19  statutes, the time within which an action shall be begun under

20  any statute of limitations runs from the time the cause of

21  action accrues.

22         (2)  Actions for products liability and fraud under s.

23  95.11(3) must be begun within the period prescribed in this

24  chapter, with the period running from the time the facts

25  giving rise to the cause of action were discovered or should

26  have been discovered with the exercise of due diligence,

27  instead of running from any date prescribed elsewhere in s.

28  95.11(3), but in no event may an action for product liability

29  or fraud under s. 95.11(3) be commenced unless the complaint

30  is served and filed within 12 years after the date of delivery

31  of the product to its first purchaser or lessee who was not


                                  1

CODING: Words stricken are deletions; words underlined are additions.






                                      HB 3871, First Engrossed/ntc



  1  engaged in the business of selling or leasing the product or

  2  of using the product as a component in the manufacture of

  3  another product or any event an action for fraud under s.

  4  95.11(3) must be begun within 12 years after the date of the

  5  commission of the alleged fraud, regardless of the date the

  6  defect in the product or the fraud was or should have been

  7  discovered. However, the 12-year limitation on filing an

  8  action for products liability does not apply if the

  9  manufacturer knew of a defect in the product and concealed or

10  attempted to conceal this defect. In addition, the 12-year

11  limitation does not apply if the claimant was exposed to or

12  used the product within the 12-year period, but an injury

13  caused by such exposure or use did not manifest itself until

14  after the 12-year period. Furthermore, the 12-year statute of

15  repose specified herein shall not apply to any aircraft other

16  than general aviation aircraft as defined in Title 49, Section

17  40101, United States Code, and, in the case of such aircraft

18  to which the federal law does not apply, the period of repose

19  under this section will be 18 years.

20         Section 2.  Section 768.1256, Florida Statutes, is

21  created to read:

22         768.1256  Government rules defense.--

23         (1)  In a product liability action brought against a

24  manufacturer or seller for harm allegedly caused by a product,

25  the jury shall be instructed that there is a rebuttable

26  presumption that the manufacturer or seller is not liable if,

27  at the time the specific unit of the product was sold or

28  delivered to the initial purchaser or user, the aspect of the

29  product that allegedly caused the harm was in compliance with

30  standards relevant to the event causing the death or injury

31  set forth in a federal or state statute or was approved by, or


                                  2

CODING: Words stricken are deletions; words underlined are additions.






                                      HB 3871, First Engrossed/ntc



  1  was in compliance with regulations or standards relevant to

  2  the event causing the death or injury promulgated by, a

  3  federal or state agency responsible for reviewing the safety

  4  of the product. Noncompliance with a standard relevant to the

  5  event causing the death or injury set forth in a federal or

  6  state statute or lack of approval by, or noncompliance with

  7  regulations or standards relevant to the event causing the

  8  death or injury promulgated by, a federal or state agency does

  9  not raise a presumption of negligence on the part of a

10  manufacturer or seller. Evidence of compliance or

11  noncompliance with a regulation or standard not relevant to

12  the event causing the death or injury is not admissible.

13         (2)  In a product liability action against a

14  manufacturer or seller, a defendant may raise an affirmative

15  defense that a product that is a drug is not defective or

16  unreasonably dangerous, if the drug was approved for safety

17  and efficacy by the United States Food and Drug Administration

18  and the drug and its labeling were in compliance with the

19  United States Food and Drug Administration's approval at the

20  time the drug left the control of the manufacturer or seller.

21  However, this subsection does not apply to a drug that is sold

22  in the United States after the effective date of an order of

23  the United States Food and Drug Administration to remove the

24  drug from the market or to withdraw its approval. This

25  subsection does not apply if the defendant at any time before

26  the event that allegedly caused the injury does any of the

27  following:

28         (a)  Intentionally withholds from or misrepresents to

29  the United States Food and Drug Administration information

30  concerning the drug that is required to be submitted under the

31  Federal Food, Drug and Cosmetic Act, chapter 675, 52 Stat.


                                  3

CODING: Words stricken are deletions; words underlined are additions.






                                      HB 3871, First Engrossed/ntc



  1  1040, 21 U.S.C. ss. 301 to 321, 331 to 343-2, 344 to 346a,

  2  347, 348 to 353, 355 to 360, 360b to 376, and 378 to 395, and

  3  the drug would not have been approved, or the United States

  4  Food and Drug Administration would have withdrawn approval

  5  for, the drug if the information had been accurately

  6  submitted; or

  7         (b)  Makes an illegal payment to an official or

  8  employee of the United States Food and Drug Administration for

  9  the purpose of securing or maintaining approval of the drug.

10         Section 3.  Any action that would not have been barred

11  under s. 95.031(2), Florida Statutes, prior to the amendments

12  to that section by this act may be commenced before June 1,

13  1999, and, if it is not commenced by that date, and is barred

14  by the amendments to s. 95.031(2), Florida Statutes, by this

15  act, shall be barred.

16         Section 4.  This act shall take effect October 1 of the

17  year in which enacted.

18

19

20

21

22

23

24

25

26

27

28

29

30

31


                                  4